Navigation Links
The 6th Latin American Conference on Lung Cancer (LALCA 2014)
Date:7/22/2014

The 6th Latin American Conference on Lung Cancer (LALCA 2014) will be held August 21 23, 2014 in Lima, Peru.

Lung Cancer is still the leading cause of death not only in Latin America but worldwide. Building on the success of the previous conferences in Chile, Mexico, Argentina and Brazil, international and national speakers will discuss the science and advances in the treatment and prevention of lung cancer and thoracic malignancies worldwide and Latin America in particular.

With tobacco being the leading cause of morbi-mortality worldwide and its consumption leading to respiratory and cardiovascular disease, as well as cancer, the Conference would like to support the Framework Convention for Tobacco Control and will again host a Tobacco Forum on Thursday, August 21.

We encourage physicians, nurses, other clinicians, researchers and scientists in the lung cancer field and those interested in any aspect of thoracic oncology to attend this conference. It is only through an exchange of the widest variety of research that we can offer the best program and benefits to our members and patients.

We expect more than 500 delegates from Latin America to attend this unique event and we encourage everyone to submit an abstract before the abstract submission deadline June 13, 2014

Simultaneous translation English >< Spanish will be provided for all sessions.


'/>"/>

Contact: Rob Mansheim
rob.mansheim@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1

Related medicine news :

1. UTSA study finds ovulating women perceive sexy cads as good dads
2. Toxic mercury, accumulating in the Arctic, springs from a hidden source
3. Elder abuse affects Latinos disproportionately
4. Internists recommend principles on role of governments in regulating patient-physician relationship
5. pH-sensitive liposomal cisplatin improves peritoneal carcinomatosis treatment without side-effects
6. Tumor suppressor genes vital to regulating blood precursor cells in fruit flies
7. Mild increases in thyroid-stimulating hormone not harmful in the elderly
8. $3.4 million HHS grant to help UIC address shortage of Latino health providers
9. Stimulating brain cells with light
10. Capturing circulating cancer cells could provide insights into how disease spreads
11. New technology allows scientists to capture and preserve cancer cells circulating in the bloodstream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: